Search PubMed⌕ Search

Biomedical subjects

Kevin K Dobbin

Publications and source records attributed to Kevin K Dobbin.

3 recordsLinked to original sources

Sample size planning for developing classifiers using high-dimensional DNA microarray data.

Many gene expression studies attempt to develop a predictor of pre-defined diagnostic or prognostic classes. If the classes are similar biologically, then the number of genes that are differentially expressed between the classes is likely to be small compared to the total number of genes measured. This motivates a two-step process for predictor development, a subset of differentially expressed genes is selected for use in the predictor and then the predictor constructed from these. Both these steps will introduce variability into the resulting classifier, so both must be incorporated in sample size estimation. We introduce a methodology for sample size determination for prediction in the context of high-dimensional data that captures variability in both steps of predictor development. The methodology is based on a parametric probability model, but permits sample size computations to be carried out in a practical manner without extensive requirements for preliminary data. We find that many prediction problems do not require a large training set of arrays for classifier development.

Computer Simulation↗

Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays.

A key step in bringing gene expression data into clinical practice is the conduct of large studies to confirm preliminary models. The performance of such confirmatory studies and the transition to clinical practice requires that microarray data from different laboratories are comparable and reproducible. We designed a study to assess the comparability of data from four laboratories that will conduct a larger microarray profiling confirmation project in lung adenocarcinomas. To test the feasibility of combining data across laboratories, frozen tumor tissues, cell line pellets, and purified RNA samples were analyzed at each of the four laboratories. Samples of each type and several subsamples from each tumor and each cell line were blinded before being distributed. The laboratories followed a common protocol for all steps of tissue processing, RNA extraction, and microarray analysis using Affymetrix Human Genome U133A arrays. High within-laboratory and between-laboratory correlations were observed on the purified RNA samples, the cell lines, and the frozen tumor tissues. Intraclass correlation within laboratories was only slightly stronger than between laboratories, and the intraclass correlation tended to be weakest for genes expressed at low levels and showing small variation. Finally, hierarchical cluster analysis revealed that the repeated samples clustered together regardless of the laboratory in which the experiments were done. The findings indicate that under properly controlled conditions it is feasible to perform complete tumor microarray analysis, from tissue processing to hybridization and scanning, at multiple independent laboratories for a single study.

Adenocarcinoma↗